4 studies found for:    delta-24
Show Display Options
Rank Status Study
1 Completed Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients
Conditions: Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Procedure: Tenckhoff Catheter placement;   Drug: Ad5-delta24RGD
2 Unknown  Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
Conditions: Brain Tumor;   Recurring Glioblastoma
Intervention: Biological: delta-24-RGD adenovirus
3 Active, not recruiting DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
Conditions: Brain Cancer;   Central Nervous System Diseases
Interventions: Drug: DNX-2401;   Procedure: Tumor Removal
4 Recruiting Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Recurrent Tumor
Intervention: Procedure: DNX2401 and Temozolomide

Indicates status has not been verified in more than two years